- •Hematuria II: causes and investigation
- •Hematospermia
- •Lower urinary tract symptoms (LUTS)
- •Nocturia and nocturnal polyuria
- •Flank pain
- •Urinary incontinence in adults
- •Genital symptoms
- •Abdominal examination in urological disease
- •Digital rectal examination (DRE)
- •Lumps in the groin
- •Lumps in the scrotum
- •2 Urological investigations
- •Urine examination
- •Urine cytology
- •Radiological imaging of the urinary tract
- •Uses of plain abdominal radiography (KUB X-ray—kidneys, ureters, bladder)
- •Intravenous pyelography (IVP)
- •Other urological contrast studies
- •Computed tomography (CT) and magnetic resonance imaging (MRI)
- •Radioisotope imaging
- •Post-void residual urine volume measurement
- •3 Bladder outlet obstruction
- •Regulation of prostate growth and development of benign prostatic hyperplasia (BPH)
- •Pathophysiology and causes of bladder outlet obstruction (BOO) and BPH
- •Benign prostatic obstruction (BPO): symptoms and signs
- •Diagnostic tests in men with LUTS thought to be due to BPH
- •Why do men seek treatment for their symptoms?
- •Watchful waiting for uncomplicated BPH
- •Medical management of BPH: combination therapy
- •Medical management of BPH: alternative drug therapy
- •Minimally invasive management of BPH: surgical alternatives to TURP
- •Invasive surgical alternatives to TURP
- •TURP and open prostatectomy
- •Indications for and technique of urethral catheterization
- •Indications for and technique of suprapubic catheterization
- •Management of nocturia and nocturnal polyuria
- •High-pressure chronic retention (HPCR)
- •Bladder outlet obstruction and retention in women
- •Urethral stricture disease
- •4 Incontinence
- •Causes and pathophysiology
- •Evaluation
- •Treatment of sphincter weakness incontinence: injection therapy
- •Treatment of sphincter weakness incontinence: retropubic suspension
- •Treatment of sphincter weakness incontinence: pubovaginal slings
- •Overactive bladder: conventional treatment
- •Overactive bladder: options for failed conventional therapy
- •“Mixed” incontinence
- •Post-prostatectomy incontinence
- •Incontinence in the elderly patient
- •Urinary tract infection: microbiology
- •Lower urinary tract infection
- •Recurrent urinary tract infection
- •Urinary tract infection: treatment
- •Acute pyelonephritis
- •Pyonephrosis and perinephric abscess
- •Other forms of pyelonephritis
- •Chronic pyelonephritis
- •Septicemia and urosepsis
- •Fournier gangrene
- •Epididymitis and orchitis
- •Periurethral abscess
- •Prostatitis: presentation, evaluation, and treatment
- •Other prostate infections
- •Interstitial cystitis
- •Tuberculosis
- •Parasitic infections
- •HIV in urological surgery
- •6 Urological neoplasia
- •Pathology and molecular biology
- •Prostate cancer: epidemiology and etiology
- •Prostate cancer: incidence, prevalence, and mortality
- •Prostate cancer pathology: premalignant lesions
- •Counseling before prostate cancer screening
- •Prostate cancer: clinical presentation
- •PSA and prostate cancer
- •PSA derivatives: free-to-total ratio, density, and velocity
- •Prostate cancer: transrectal ultrasonography and biopsies
- •Prostate cancer staging
- •Prostate cancer grading
- •General principles of management of localized prostate cancer
- •Management of localized prostate cancer: watchful waiting and active surveillance
- •Management of localized prostate cancer: radical prostatectomy
- •Postoperative course after radical prostatectomy
- •Prostate cancer control with radical prostatectomy
- •Management of localized prostate cancer: radical external beam radiotherapy (EBRT)
- •Management of localized prostate cancer: brachytherapy (BT)
- •Management of localized and radiorecurrent prostate cancer: cryotherapy and HIFU
- •Management of locally advanced nonmetastatic prostate cancer (T3–4 N0M0)
- •Management of advanced prostate cancer: hormone therapy I
- •Management of advanced prostate cancer: hormone therapy II
- •Management of advanced prostate cancer: hormone therapy III
- •Management of advanced prostate cancer: androgen-independent/ castration-resistant disease
- •Palliative management of prostate cancer
- •Prostate cancer: prevention; complementary and alternative therapies
- •Bladder cancer: epidemiology and etiology
- •Bladder cancer: pathology and staging
- •Bladder cancer: presentation
- •Bladder cancer: diagnosis and staging
- •Muscle-invasive bladder cancer: surgical management of localized (pT2/3a) disease
- •Muscle-invasive bladder cancer: radical and palliative radiotherapy
- •Muscle-invasive bladder cancer: management of locally advanced and metastatic disease
- •Bladder cancer: urinary diversion after cystectomy
- •Transitional cell carcinoma (UC) of the renal pelvis and ureter
- •Radiological assessment of renal masses
- •Benign renal masses
- •Renal cell carcinoma: epidemiology and etiology
- •Renal cell carcinoma: pathology, staging, and prognosis
- •Renal cell carcinoma: presentation and investigations
- •Renal cell carcinoma: active surveillance
- •Renal cell carcinoma: surgical treatment I
- •Renal cell carcinoma: surgical treatment II
- •Renal cell carcinoma: management of metastatic disease
- •Testicular cancer: epidemiology and etiology
- •Testicular cancer: clinical presentation
- •Testicular cancer: serum markers
- •Testicular cancer: pathology and staging
- •Testicular cancer: prognostic staging system for metastatic germ cell cancer
- •Testicular cancer: management of non-seminomatous germ cell tumors (NSGCT)
- •Testicular cancer: management of seminoma, IGCN, and lymphoma
- •Penile neoplasia: benign, viral-related, and premalignant lesions
- •Penile cancer: epidemiology, risk factors, and pathology
- •Squamous cell carcinoma of the penis: clinical management
- •Carcinoma of the scrotum
- •Tumors of the testicular adnexa
- •Urethral cancer
- •Wilms tumor and neuroblastoma
- •7 Miscellaneous urological diseases of the kidney
- •Cystic renal disease: simple cysts
- •Cystic renal disease: calyceal diverticulum
- •Cystic renal disease: medullary sponge kidney (MSK)
- •Acquired renal cystic disease (ARCD)
- •Autosomal dominant (adult) polycystic kidney disease (ADPKD)
- •Ureteropelvic junction (UPJ) obstruction in adults
- •Anomalies of renal ascent and fusion: horseshoe kidney, pelvic kidney, malrotation
- •Renal duplications
- •8 Stone disease
- •Kidney stones: epidemiology
- •Kidney stones: types and predisposing factors
- •Kidney stones: mechanisms of formation
- •Evaluation of the stone former
- •Kidney stones: presentation and diagnosis
- •Kidney stone treatment options: watchful waiting
- •Stone fragmentation techniques: extracorporeal lithotripsy (ESWL)
- •Intracorporeal techniques of stone fragmentation (fragmentation within the body)
- •Kidney stone treatment: percutaneous nephrolithotomy (PCNL)
- •Kidney stones: open stone surgery
- •Kidney stones: medical therapy (dissolution therapy)
- •Ureteric stones: presentation
- •Ureteric stones: diagnostic radiological imaging
- •Ureteric stones: acute management
- •Ureteric stones: indications for intervention to relieve obstruction and/or remove the stone
- •Ureteric stone treatment
- •Treatment options for ureteric stones
- •Prevention of calcium oxalate stone formation
- •Bladder stones
- •Management of ureteric stones in pregnancy
- •Hydronephrosis
- •Management of ureteric strictures (other than UPJ obstruction)
- •Pathophysiology of urinary tract obstruction
- •Ureter innervation
- •10 Trauma to the urinary tract and other urological emergencies
- •Renal trauma: clinical and radiological assessment
- •Renal trauma: treatment
- •Ureteral injuries: mechanisms and diagnosis
- •Ureteral injuries: management
- •Bladder and urethral injuries associated with pelvic fractures
- •Bladder injuries
- •Posterior urethral injuries in males and urethral injuries in females
- •Anterior urethral injuries
- •Testicular injuries
- •Penile injuries
- •Torsion of the testis and testicular appendages
- •Paraphimosis
- •Malignant ureteral obstruction
- •Spinal cord and cauda equina compression
- •11 Infertility
- •Male reproductive physiology
- •Etiology and evaluation of male infertility
- •Lab investigation of male infertility
- •Oligospermia and azoospermia
- •Varicocele
- •Treatment options for male factor infertility
- •12 Disorders of erectile function, ejaculation, and seminal vesicles
- •Physiology of erection and ejaculation
- •Impotence: evaluation
- •Impotence: treatment
- •Retrograde ejaculation
- •Peyronie’s disease
- •Priapism
- •13 Neuropathic bladder
- •Innervation of the lower urinary tract (LUT)
- •Physiology of urine storage and micturition
- •Bladder and sphincter behavior in the patient with neurological disease
- •The neuropathic lower urinary tract: clinical consequences of storage and emptying problems
- •Bladder management techniques for the neuropathic patient
- •Catheters and sheaths and the neuropathic patient
- •Management of incontinence in the neuropathic patient
- •Management of recurrent urinary tract infections (UTIs) in the neuropathic patient
- •Management of hydronephrosis in the neuropathic patient
- •Bladder dysfunction in multiple sclerosis, in Parkinson disease, after stroke, and in other neurological disease
- •Neuromodulation in lower urinary tract dysfunction
- •14 Urological problems in pregnancy
- •Physiological and anatomical changes in the urinary tract
- •Urinary tract infection (UTI)
- •Hydronephrosis
- •15 Pediatric urology
- •Embryology: urinary tract
- •Undescended testes
- •Urinary tract infection (UTI)
- •Ectopic ureter
- •Ureterocele
- •Ureteropelvic junction (UPJ) obstruction
- •Hypospadias
- •Normal sexual differentiation
- •Abnormal sexual differentiation
- •Cystic kidney disease
- •Exstrophy
- •Epispadias
- •Posterior urethral valves
- •Non-neurogenic voiding dysfunction
- •Nocturnal enuresis
- •16 Urological surgery and equipment
- •Preparation of the patient for urological surgery
- •Antibiotic prophylaxis in urological surgery
- •Complications of surgery in general: DVT and PE
- •Fluid balance and management of shock in the surgical patient
- •Patient safety in the operating room
- •Transurethral resection (TUR) syndrome
- •Catheters and drains in urological surgery
- •Guide wires
- •JJ stents
- •Lasers in urological surgery
- •Diathermy
- •Sterilization of urological equipment
- •Telescopes and light sources in urological endoscopy
- •Consent: general principles
- •Cystoscopy
- •Transurethral resection of the prostate (TURP)
- •Transurethral resection of bladder tumor (TURBT)
- •Optical urethrotomy
- •Circumcision
- •Hydrocele and epididymal cyst removal
- •Nesbit procedure
- •Vasectomy and vasovasostomy
- •Orchiectomy
- •Urological incisions
- •JJ stent insertion
- •Nephrectomy and nephroureterectomy
- •Radical prostatectomy
- •Radical cystectomy
- •Ileal conduit
- •Percutaneous nephrolithotomy (PCNL)
- •Ureteroscopes and ureteroscopy
- •Pyeloplasty
- •Laparoscopic surgery
- •Endoscopic cystolitholapaxy and (open) cystolithotomy
- •Scrotal exploration for torsion and orchiopexy
- •17 Basic science of relevance to urological practice
- •Physiology of bladder and urethra
- •Renal anatomy: renal blood flow and renal function
- •Renal physiology: regulation of water balance
- •Renal physiology: regulation of sodium and potassium excretion
- •Renal physiology: acid–base balance
- •18 Urological eponyms
- •Index
346 CHAPTER 7 Miscellaneous urological diseases of kidney
Ureteropelvic junction (UPJ) obstruction in adults
Ureteropelvic junction (UPJ) obstruction is an obstruction of the proximal ureter at the junction with the renal pelvis resulting in a restriction of urine flow. It is known as pelviureteric junction obstruction (PUJO) outside of the United States.
Epidemiology
This affects more males than females (5:2 ratio). In unilateral cases, the left side is affected more often than the right; 10–15% of cases are bilateral.
Etiology
Congenital
-Intrinsic: Smooth muscle defect results in an aperistaltic segment of ureter at the UPJ.
-Extrinsic: compression from lower renal pole vessel over which the UPJ runs. It is unlikely that these vessels are the primary cause of the obstruction. It is more probable that UPJ obstruction leads to a dilated UPJ and ballooning of the renal pelvis over the lower pole
vessels, which may contribute to, but is not the primary cause of, the obstruction.
-Acquired: UPJ stricture secondary to ureteral manipulation (e.g., ureteroscopy); trauma from passage of calculi; fibroepithelial polyps; TCC of urothelium at UPJ; external compression of ureter by retroperitoneal fibrosis or malignancy
Presentation
Patients present with flank pain precipitated by a diuresis (high fluid intake; especially precipitated by consumption of alcohol), flank mass, UTI, and hematuria (after minor trauma). It may also be associated with vesicoureteric reflux (VUR).
Investigation
Renal ultrasound shows renal pelvis dilatation in the absence of a dilated ureter. IVP demonstrates delay of excretion of contrast and a dilated pelvicalyceal system. Arrange for a CT, to exclude a small, radiolucent stone, urothelial TCC, or retroperitoneal pathology that may be the cause of the obstruction at the UPJ.
MAG3 renography with administration of Lasix to establish a maximum diuresis is the definitive diagnostic test for UPJ obstruction. Radioisotope accumulates in the renal pelvis, and following IV Lasix it continues to accumulate (a rising curve).
Many urologists perform retrograde pyelography to establish the exact site of the obstruction, but they do this at the time of UPJ repair to avoid introducing infection into an obstructed renal pelvis.
URETEROPELVIC JUNCTION (UPJ) OBSTRUCTION IN ADULTS 347
Treatment
Surgery
Surgery is indicated for recurrent episodes of bothersome pain, renal impairment, when a stone has developed in the obstructed kidney, and when infection (pyonephrosis) has supervened.
In the absence of symptoms, consider watchful waiting with serial MAG3 renograms. If renal function remains stable and the patient remains free of symptoms, there is no need to operate.
Endoscopic treatment of a UPJ obstruction is called an endopyelotomy (or pyelolysis). Various techniques have been described, but the essential principle is the same—full-thickness incision through the obstructing proximal ureter, from within the lumen of the ureter down into the peripelvic and periureteral fat, using a sharp knife or holmium:YAG laser. The incision is stented for 4 weeks to allow re-epithelialization of the UPJ. The procedure is relatively minimally invasive and is generally not used for UPJ obstruction >2 cm in length.
The incision may be made percutaneously or by a retrograde approach via a rigid or flexible ureteroscope, or by using a specially designed endopyelotomy balloon (the Acucise® technique). An angioplasty-type balloon over which a cautery wire runs is inflated across the UPJ. Passage of an electrical current heats the wire and this cuts through the obstructing ring of tissue at the UPJ.
The presence of a combination of UPJ obstruction and a renal stone that is suitable for PCNL is an indication for combined PCNL and percutaneous endopyelotomy.
Success rates in terms of relieving obstruction are as follows: percutaneous endopyelotomy, 60–100% (mean 70%); cautery wire balloon endopyelotomy, 70%; ureteroscopic endopyelotomy, 80%.
Pyeloplasty
-Open pyeloplasty has success rates of 95% and may also be used after endopyelotomy failure or as a first-line technique.
-Laparoscopic or robotic-assisted pyeloplasty has the advantage of accelerated patient recovery, with success rates of 95%.
•Common techniques include dismembered pyeloplasty (also known as the Anderson–Hynes pyeloplasty: the narrowed area of UPJ is excised, the proximal ureter is spatulated and anastomosed to the renal pelvis), flap pyeloplasty (Culp), and Y-V-plasty (Foley).
348 CHAPTER 7 Miscellaneous urological diseases of kidney
Anomalies of renal ascent and fusion: horseshoe kidney, pelvic kidney, malrotation
Abnormalities of renal ascent and fusion occur in weeks 6–9 of gestation, when the embryonic kidney is ascending to its definitive lumbar position (ascending as a result of rapid caudal growth of the embryo).
Horseshoe kidney
This is the most common example of renal fusion. Prevalence is 1 in 400, with a male-to-female ratio 2:1.
The kidneys lie vertically (instead of obliquely) and are joined at their lower poles (in 95%) by midline parenchymal tissue (the isthmus). The inferior mesenteric artery obstructs ascent of the isthmus. Consequently, the horseshoe kidney lies lower in the abdomen (at L3 or L4 vertebral level).
Normal rotation of the kidney is also prevented, thus the renal pelvis lies anteriorly, with the ureters also passing anteriorly over the kidneys and isthmus (but entering the bladder normally). Blood supply is variable, usually from one or more renal arteries or their branches, or from branches off the aorta or inferior mesenteric artery (see Fig. 7.2).
A proportion of individuals with horseshoe kidneys have associated congenital abnormalities (Turner syndrome, trisomy 18, genitourinary anomalies, ureteric duplication), vesicoureteric reflux, UPJ obstruction, and renal tumors (including Wilm tumors).
Most patients with horseshoe kidneys remain asymptomatic; however, infection and calculi may develop and cause symptoms. The diagnosis is usually suggested on renal ultrasound and confirmed by IVP (calyces of the lower renal pole are seen to point medially, and lie medially in relation to the ureters) or CT. Renal function is usually normal.
Pelvic kidney
This represents a form of renal ectopia. Prevalence is 1 in 2000–3000, with both sexes affected equally.
The left kidney is affected more often than the right, and bilateral cases are seen in <10%. The affected kidney is smaller, with the renal pelvis positioned anteriorly (instead of medially), and the ureter is short but enters the bladder normally.
Pelvic kidneys lie opposite the sacrum and below the aortic bifurcation and are supplied by adjacent (aberrant) vessels (see Fig. 7.3). There is an increased risk of congenital anomalies, including contralateral renal agenesis and genital malformations.
Most cases are asymptomatic. Diagnosis is made on renal ultrasound scan, IVP, or renography. Complications include obstruction, hydronephrosis, and infection.
ANOMALIES OF RENAL ASCENT AND FUSION 349
Horseshoe kidney (vertical orientation)
Anterior renal pelvis
Ureter (running anterior to kidney)
Isthmus
Bony pelvis
Bladder
Figure 7.2 Horseshoe kidney.
Smaller pelvic kidney
Anterior renal pelvis
Short ureter
Figure 7.3 Pelvic (ectopic) kidney.
350 CHAPTER 7 Miscellaneous urological diseases of kidney
Malrotation
The kidney is located in a normal position, but the renal pelvis fails to rotate from an anterior to a medial orientation. Prevalence is ~1 in 1000, with a male-to-female ratio of 2:1. The renal shape may be altered (flattened, oval, triangular, or elongated) and the kidney retains its fetal lobulated outline (see Fig. 7.4).
It is associated with increased deposition of fibrous tissue around the renal hilum, which can produce symptoms due to ureteric or UPJ obstruction (causing hydronephrosis, infection, or stone formation). Most patients, however, remain asymptomatic.
The diagnosis is made on renal ultrasound scan, IVP, or retrograde pyelography.
ANOMALIES OF RENAL ASCENT AND FUSION 351
Altered renal shape (with fetal lobulations)
Anterior renal pelvis
Ureter
Bladder
Figure 7.4 Malrotation of the kidney.